Cancer Home > Velcade Off-Label

The approved uses for Velcade® (bortezomib) include the treatment of multiple myeloma (a type of cancer of the bone marrow) and mantle cell lymphoma (a type of cancer of the white blood cells). However, there are also certain circumstances when a healthcare provider may prescribe this medicine for other uses. These are called unapproved, or "off-label," uses. Some of the off-label Velcade uses include treatment of the following conditions:
 
  • Cutaneous T-cell lymphoma
  • Peripheral T-cell lymphoma
  • Amyloidosis.
 
As a type of proteasome inhibitor, Velcade works by blocking the action of proteasomes (proteins found inside both healthy and cancerous cells). This causes certain proteins to accumulate within the cancer and healthy cells, causing them to die.
 
(To learn more about these off-label uses, click Velcade Uses. This article further discusses what this medicine is used for and takes a more in-depth look at how it works.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Advertisement
Topics

Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.